Order results by:
| Issue | Title | |
| Vol 3, No 3 (2007) | REDUCTION OF CUMULATIVE CARDIOVASCULAR RISK IN PATIENTS WITH ARTERIAL HYPERTENSION: THE ROLE OF ANGIOTENSIN CONVERTING ENZYME INHIBITORS ACCORDING TO THE NEW EUROPEAN RECOMMENDATIONS | Abstract similar documents |
| M. N. Mamedov, N. A. Chepurina, Z. N. Tokareva, A. A. Evdokimova | ||
| "... studies. In high risk patients monotherapy with Enam (enalapril, Dr. Reddy’s) decreases blood pressure ..." | ||
| Vol 3, No 5 (2007) | CUMULATIVE CARDIO-VASCULAR RISK IN HYPERTENSIVE PATIENTS: EFFECTS OF ANGIOTENSIN CONVERTING ENZYME INHIBITORS | Abstract similar documents |
| L. I. Katelnitskaya, L. A. Haisheva, S. E. Glova | ||
| "... Aim. To assess cumulative cardio-vascular (CV) risk and elasticity of big-to-middle size arteries ..." | ||
| Vol 2, No 3 (2006) | COMPARATIVE RESEARCH OF ENALAPRIL AND ATENOLOL ANTIHYPERTENSIVE EFFICACY IN HIGH RISK PATIENTS | Abstract similar documents |
| O. M. Moiseeva, S. V. Villevalde, I. V. Emelyanov, T. G. Ivanova | ||
| "... Aim. To evaluate the effecacy of enalapril (Enam, Dr.Reddy’s, India) and atenolol (Tenormin ..." | ||
| Vol 5, No 6 (2009) | ORGANOPROTECTIVE EFFECTS OF THE FIXED COMBINATION OF ANGIOTENSIN-CONVERTING ENZYME INHIBITOR LISINOPRIL AND DIURETIC HYDROCHLOROTHIAZIDE | Abstract similar documents |
| E. A. Ryabikhin, M. E. Mozheiko | ||
| "... pressure (BP) level, body mass index, biochemical markers and risk factors were evaluated initially ..." | ||
| Vol 5, No 6 (2009) | EXPERIENCE OF RAMIPRIL (HARTIL) USAGE IN PATIENTS WITH HIGH CARDIOVASCULAR RISK (THE OPTIMIST STUDY) | Abstract similar documents |
| I. A. Velizhanina, L. I. Gapon, E. S. Velizhanina, M. I. Shupina, A. V. Rudakov, T. S. Bondarenko | ||
| "... with different cardiovascular risk (according to arterial hypertension (HT) risk stratification) in real clinical ..." | ||
| Vol 5, No 1 (2009) | SAFARI - RANDOMISED TRIAL ON COMPLEX THERAPY OF ARTERIAL HYPERTENSION AND DISLIPIDEMY. THE MAIN RESULTS | Abstract similar documents |
| S. Y. Martsevich, N. P. Kutishenko, V. V. Yakusevich, A. D. Deev, A. A. Serazhim, T. V. Bobkova, L. P. Volkonskaya, V. P. Voronina, N. A. Dmitrieva, O. V. Lerman, J. V. Lukina, M. A. Maksimova, A. A. Serazhim, S. N. Tolpygina, E. V. Shilova | ||
| "... Aim. To evaluate possibility of complex pharmaceutical effect simultaneously on 2 risk factors ..." | ||
| Vol 6, No 1 (2010) | COMPARISON OF NEW GENERIC AND ORIGINAL RAMIPRIL IN PATIENTS WITH ARTERIAL HYPERTENSION AND HIGH CARDIOVASCULAR RISK | Abstract PDF (Eng) similar documents |
| S. Yu. Martsevich, Yu. V. Lukina, N. A. Dmitrieva, O. V. Lerman, S. N. Tolpygina, A. A. Serazhim, V. P. Voronina, M. A. Maksimova, L. Yu. Drozdova, A. V. Zakharova | ||
| "... with arterial hypertension (HT) of 1-2 degree and high cardiovascular risk, and to evaluate target blood ..." | ||
| Vol 4, No 1 (2008) | MICROALBUMINURIA AS A FORECAST FACTOR FOR CARDIO-VASCULAR COMPLICATIONS AND A MARKER OF THERAPY EFFICACY IN PATIENTS WITH ARTERIAL HYPERTENSION | Abstract similar documents |
| L. A. Haisheva, L. I. Katelnitskaya | ||
| "... hypertension (HT) and evaluate the possibilities to reduce in fatal cardiovascular risk due to lisinopril ..." | ||
| Vol 15, No 1 (2019) | New Guidelines on Management of Arterial Hypertension: Key Similarities and Differences | Abstract similar documents |
| Zh. D. Kobalava, E. A. Troitskaya, E. L. Kolesnik | ||
| "... the importance of cardiovascular risk evaluation for treatment initiation and choice of optimal treatment ..." | ||
| Vol 16, No 3 (2020) | Economic Burden of Hypertension in the Russian Federation | Abstract similar documents |
| Yu. A. Balanova, A. V. Kontsevaya, A. O. Myrzamatova, D. K. Mukaneeva, M. B. Khudyakov, O. M. Drapkina | ||
| "... and methods. The calculation included the prevalence of hypertension in the RF and the relative risk ..." | ||
| Vol 6, No 4 (2010) | PHARMACOECONOMIC ANALYSIS OF CARVEDILOL THERAPY IN PATIENTS WITH ARTERIAL HYPERTENSION AND METABOLIC RISK FACTORS (ACCORDING TO THE CAMELLIA STUDY) | Abstract similar documents |
| S. Y. Martsevich, N. P. Kutishenko, A. D. Deev, S. A. Shalnova, R. G. Oganov | ||
| "... . To assess effects of carvedilol therapy on 10-year expected risk of cardiovascular complications (CVC ..." | ||
| Vol 6, No 1 (2010) | HEMODYNAMIC AND METABOLIC EFFECTS OF NEBIVOLOL IN LOCOMOTIVE CREW STAFF WITH NEWLY DIAGNOSED ARTERIAL HYPERTENSION | Abstract similar documents |
| I. V. Osipova, O. N. Antropova, E. I. Bravkova, A. G. Zaltsman, T. B. Belousova, T. V. Perevozchikova, I. A. Batanina | ||
| "... with moderate-to-high cardiovascular risk were included into the open prospective uncontrolled study. The study ..." | ||
| Vol 7, No 4 (2011) | SARTANS OF THE SECOND GENERATION: THERAPEUTIC POTENTIAL EXTENSION | Abstract similar documents |
| S. V. Nedogoda | ||
| Vol 16, No 6 (2020) | Thiazide and Thiazide-like Diuretics in the Treatment of Arterial Hypertension: are there Any Differences? | Abstract similar documents |
| A. I. Kochetkov | ||
| "... В действующих клинических рекомендациях по артериальной гипертонии (АГ) диуретики рассматриваются ..." | ||
| Vol 4, No 5 (2008) | EVALUATION OF QUALITY OF ARTERIAL HYPERTENSION CONTROL IN POPULATION OF VOLOGDA REGION | Abstract similar documents |
| A. I. Popugaev, G. Т Banshikov, A. A. Kolinko, N. A. Korolenko, R. A. Kasimov, Д. А. Rybakov, А. М. Kalinina | ||
| "... in villages take antihypertensive drugs more often, but they have more risk factors and associate conditions ..." | ||
| Vol 6, No 3 (2010) | ASSOCIATION OF CLINICAL AND GENETIC FACTORS WITH LEFT VENTRICLE HYPERTROPHY IN ARTERIAL HYPERTENSION | Abstract PDF (Eng) similar documents |
| T. Yu. Kuznetsova, D. V. Gavrilov, L. M. Samohodskaya, D. V. Rebrikov, S. A. Morozova, P. I. Makarevich, A. V. Kolotvin, A. B. Balatsky, A. Yu. Postnov, S. A. Boitsov | ||
| "... ,005) or diabetes (OR 3,33, р<0,0001) presence. At genetic factors evaluation decrease of LVH risk was revealed ..." | ||
| Vol 7, No 5 (2011) | AMLODIPINE IN CORRECTION OF HIGH RISK ARTERIAL HYPERTENSION: FOCUS ON MECHANISMS OF INFLAMMATION | Abstract similar documents |
| A. A. Tarasov, S. I. Davydov, T. A. Bezborodova, M. A. Gordeeva, A. R. Babaeva | ||
| "... безопасность у пациентов с артериальной гипертонией (АГ) в сочетании с ишемической болезнью сердца (ИБС) или ..." | ||
| Vol 1, No 2 (2005) | THE STATE OF ARTERIAL HYPERTENSION DIAGNOSTICS AND TREATMENT, ACCORDING TO THE RESULTS OF THE POLL AMONG PHYSICIANS OF VOLGOGRAD AND VOLGOGRAD REGION | Abstract similar documents |
| S. Y. Martsevich, N. S. Oganisyan, N. A. Dmitrieva, A. V. Klimakov | ||
| "... is revealed. Insufficient knowledge of criteria for division patients according to the risk category ..." | ||
| Vol 13, No 5 (2017) | IS IT POSSIBLE TO IMPROVE THE ADHERENCE TO TREATMENT OF HYPERTENSION AND DYSLIPIDEMIA IN PATIENTS WITHOUT CLINICAL MANIFESTATIONS OF ATHEROSCLEROSIS? | Abstract similar documents |
| A. А. Sarycheva, D. V. Nebieridze, T. V. Kamyshova | ||
| "... at high risk is critical in reducing morbidity and mortality from cardiovascular diseases. Aim. To assess ..." | ||
| Vol 13, No 6 (2017) | RISK FACTORS OF ARTERIAL HYPERTENSION IN ORGANIZED COHORT OF MALE EMPLOYEES OF THE MACHINE BUILDING PLANT | Abstract similar documents |
| A. N. Britov, S. A. Tjupaeva, N. A. Eliseeva, A. N. Meshkov, A. D. Deev | ||
| "... Aim. To study the incidence of arterial hypertension (HT) and prevalence of risk factors ..." | ||
| Vol 8, No 1 (2012) | EFFICACY OF FIXED COMBINATION OF VALSARTAN, AMLODIPINE AND HYDROCHLOROTHIAZIDE IN COMPLEX THERAPY OF THE PATIENT OF VERY HIGH CARDIOVASCULAR RISK | Abstract similar documents |
| I. M. Sokolov, N. A. Zheleznyakova | ||
| "... risk requires widespread use of combined therapy. Current approaches to selection of combination ..." | ||
| Vol 16, No 5 (2020) | Hypertension and Hypercholesterolemia: is it Time for Anti-«Lipitensive» Therapy? | Abstract similar documents |
| Z. D. Kobalava, E. V. Kokhan | ||
| "... Despite the widespread awareness that hypertension and dyslipidemia are risk factors of prime ..." | ||
| Vol 13, No 2 (2017) | COMBINATION THERAPY OF HIGH-RISK PATIENTS IN REAL CLINICAL PRACTICE. RESULTS OF SYNERGY STUDY. PART 1. ANTIHYPERTENSIVE BRANCH | Abstract similar documents |
| O. M. Drapkina | ||
| "... исследование включено 24 008 пациентов с артериальной гипертонией (АГ) и дислипидемией. Исследователи были ..." | ||
| Vol 14, No 6 (2018) | Antihypertensive Efficacy of Fixed Combination of Amlodipine and Ramipril in Patients with Arterial Hypertension and Very High Cardiovascular Risk | Abstract PDF (Eng) similar documents |
| O. Yu. Korennova, S. P. Podolnaya, E. P. Prihodko, E. A. Turusheva, S. N. Starinskaya, I. A. Вratishko, I. V. Druk | ||
| "... of amlodipine and ramipril in hypertensive patients with very high cardiovascular risk. Material and methods ..." | ||
| Vol 4, No 4 (2008) | DANGER OF ALCOHOL FOR PATIENTS WITH ARTERIAL HYPERTENSION DURING ANTIHYPERTENSIVE THERAPY | Abstract similar documents |
| M. P. Savenkov, M. K. Danilova, S. N. Ivanov, A. M. Savenkova, S. V. Ivanova | ||
| "... antihypertensive therapy. Conclusion. It is necessary to inform the patient about risk of alcohol taking ..." | ||
| Vol 6, No 1 (2010) | EVOLUTION STAGES OF LOW RENIN HYPERTENSION | Abstract similar documents |
| S. V. Akhadov, G. R. Ruzbanova, G. S. Molchanovа | ||
| "... and the high cardiovascular risk were included into the study. All patients received ACE inhibitor, enalapril ..." | ||
| Vol 5, No 4 (2009) | CHANGE OF CARDIOVASCULAR RISK FACTORS AND QUALITY OF LIFE IN YOUNG HYPERTENSIVE PATIENTS AS A RESULT OF PREVENTIVE CONSULTATION IN PRIMARY HEALTH CARE | Abstract similar documents |
| M. I. Shupina | ||
| "... and methods. 114 young patients with arterial hypertension, stage 1, and low and moderate cardiovascular risk ..." | ||
| Vol 3, No 4 (2007) | PREVALENCE OF ARTERIAL HYPERTENSION, ASSOCIATED DISEASES AND END-ORGAN DAMAGES IN REPUBLIC OF BASHKORTOSTAN | Abstract similar documents |
| T. V. Lukmanova, I. M. Karamova, N. H. Sharafutdinova | ||
| "... into account risk factors. ..." | ||
| Vol 6, No 2 (2010) | REFRACTORY HYPERTENSION – MODERN APPROACHES TO DIAGNOSTICS AND TREATMENT | Abstract similar documents |
| A. N. Britov, M. M. Bystrova | ||
| "... of reversible risk factors and reasons of the secondary HT, use of the effective combined therapy ..." | ||
| Vol 4, No 1 (2008) | ACUTE CEREBROVASCULAR EVENTS IN PATIENTS WITH ARTERIAL HYPERTENSION: MOLECULAR GENETIC ASPECTS | Abstract similar documents |
| M. A. Karpenko, E. G. Shatskaya, V. N. Solntsev, M. A. Bogdanov, V. I. Larionova | ||
| "... gene polymorphism and C677T of MTHFR gene polymorphism. The high risk markers are C-allele of ATR1 gene ..." | ||
| Vol 7, No 4 (2011) | USE OF FIXED COMBINATIONS OF RAMIPRIL AND HYDROCHLOROTHIAZIDE IN PATIENTS WITH ARTERIAL HYPERTENSION AND HIGH OR VERY HIGH CARDIOVASCULAR RISK (OPTIMIST 2 STUDY): RESULTS OF THE NONCOMPARATIVE STUDY | Abstract similar documents |
| I. A. Velizhanina, L. I. Gapon, E. S. Velizhanina, A. V. Rudakov, T. S. Zhupanova | ||
| "... and hydrochlorothiazide in patients with arterial hypertension (HT) 2-3 degree and high or very high cardiovascular risk ..." | ||
| Vol 7, No 3 (2011) | COMPARATIVE ANALYSIS OF ARTERIAL HYPERTENSION TREATMENT IN MEN AND WOMEN BASED ON THE RESULTS OF ACCORD STUDY (ACRIDILOLE IN COMBINATION THERAPY IN PATIENTS WITH ARTERIAL HYPERTENSION AND OBESITY OR TYPE 2 DIABETES) | Abstract similar documents |
| S. A. Shalnova, S. Yu. Martsevich, A. D. Deev, Yu. V. Lukina, E. N. Hoseva | ||
| "... men and women with concomitant diseases and high metabolic and cardiovascular risk. ..." | ||
| Vol 5, No 3 (2009) | CONTEMPORARY PROBLEMS OF EVALUATION OF HYPERTENSION TREATMENT EFFICACY: MASKED HYPERTENSION AND WHITE COAT HYPERTENSION | Abstract similar documents |
| V. M. Gorbunov, M. I. Smirnovа | ||
| "... % of patients. The cardiovascular risk in these patients does not differ significantly from the risk in patients ..." | ||
| Vol 2, No 2 (2006) | STROKE PREVENTION IN HYPERTENSIVE PATIENTS | Abstract similar documents |
| S. Y. Martsevich, V. A. Egorov | ||
| "... is considered. Stroke risk factors including arterial hypertension are described. The main pharmacotherapy ways ..." | ||
| Vol 13, No 5 (2017) | CHRONOTHERAPY OF HYPERTENSION: CURRENT STATE OF THE SCIENTIFIC PROBLEM | Abstract similar documents |
| V. M. Gorbunov, E. Y. Fedorova, E. V. Platonova | ||
| "... of cardiovascular complications risk reduction by normalizing the circadian rhythm of BP due to the bed-time ..." | ||
| Vol 3, No 4 (2007) | EDUCATIONAL MASTER-CLASS ON ARTERIAL HYPERTENSION AND CARDIOVASCULAR RISK. MOSCOW, SEPTEMBER 12-13, 2007 | Abstract similar documents |
| "... Educational master-class on arterial hypertension and cardiovascular risk. Moscow, September 12-13 ..." | ||
| Vol 15, No 6 (2019) | Current Trends in the Treatment of Hypertension: Focus on Improving Prognosis. The Capabilities of an Amlodipine/Telmisartan Single-Pill Combination | Abstract similar documents |
| O. D. Ostroumova, A. I. Kochetkov | ||
| "... подавляющему большинству пациентов с артериальной гипертонией (АГ) уже на старте лечения фиксированных ..." | ||
| Vol 4, No 2 (2008) | DIHYDROPYRIDINE CALCIUM ANTAGONISTS: THE ROLE IN CURRENT THERAPY OF CARDIO-VASCULAR DISEASES | Abstract similar documents |
| E. V. Shilova, S. Y. Martsevich | ||
| "... (STONE, STOP-Hypertension-2, ALLHAT, ASCOT-BPLA etc.) devoted to estimation of CA effects on the risk ..." | ||
| Vol 2, No 4 (2006) | CALCIUM ANTAGONISTS IN THE TREATMENT OF ARTERIAL HYPERTENSION DURING PREGNANCY | Abstract similar documents |
| R. I. Striuk | ||
| "... . Hypertensive pregnant patients of high and low risk are defined. Non-pharmacological treatment of pregnant ..." | ||
| Vol 11, No 2 (2015) | THE INFLUENCE OF INSULIN RESISTANCE ON THE FORMATION AND PROGRESSION OF METABOLIC SYNDROME COMPONENTS (THE RESULTS OF A FIVE-YEAR STUDY) | Abstract similar documents |
| G. E. Roytberg, J. V. Dorosh, O. O. Sharkhun | ||
| "... The combination of risk factors that make up a metabolic syndrome increases the risk ..." | ||
| Vol 9, No 4 (2013) | NORVASC® IN RUSSIA 20 YEARS LATER: CONTINUATION OF THE HISTORY | Abstract similar documents |
| A. V. Rudenko, B. A. Rudenko | ||
| "... in the presence of both risk factors and associated clinical conditions. Amlodipine therapy significantly reduced ..." | ||
| Vol 6, No 4 (2010) | EFFECT OF ANTIHYPERTENSIVE THERAPY ON METABOLIC PROFILE AND ERECTILE FUNCTION IN HYPERTENSIVE MEN WITH HIGH CARDIOVASCULAR RISK: FOCUS ON THE COMBINATION OF LISINOPRIL AND AMLODIPINE | Abstract similar documents |
| M. N. Mamedov, M. V. Stroeva, M. N. Kovrigina, E. A. Poddubskaya | ||
| "... in hypertensive men with high cardiovascular risk. Materials and methods. Hypertensive men (n=21) with high ..." | ||
| Vol 14, No 3 (2018) | TRIPLE ANTIHYPERTENSIVE THERAPY: FOCUS ON EFFICACY AND PROGNOSIS | Abstract similar documents |
| O. D. Ostroumova, A. I. Kochetkov, A. V. Starodubova, I. V. Goloborodova, E. A. Smolyarchuk | ||
| "... ability to reduce cardiovascular risk are presented. Current data are presented about their use in a fixed ..." | ||
| Vol 8, No 6 (2012) | MODERN VIEWS ON THE VARIABILITY OF BLOOD PRESSURE | Abstract similar documents |
| V. M. Gorbunov | ||
| "... of atenolol/diuretic group during the follow-up that was associated with a lower risk of cardiovascular ..." | ||
| Vol 7, No 6 (2011) | PHARMACOTHERAPY QUALITY IN PATIENTS WITH ARTERIAL HYPERTENSION OBSERVED IN PRIMARY CARE PRACTICE. HYPERTENSION REGISTER DATA | Abstract similar documents |
| O. M. Posnenkova, A. R. Kiselev, V. I. Gridnev, V. A. Shvartz, P. Ya. Dovgalevsky, E. V. Oschepkova | ||
| "... . Compliance with recommendations on decision making about pharmacotherapy need (risk category assessment ..." | ||
| Vol 18, No 4 (2022) | Therapeutic Options for the Single Pill Combination of Lisinopril, Amlodipine and Rosuvastatin: a Systematic Review | Abstract similar documents |
| S. R. Gilyarevsky, M. V. Golshmid, N. G. Bendeliani | ||
| "... pressure and LDL-C in a wide range of patients with different baseline risk of developing cardiovascular ..." | ||
| Vol 10, No 5 (2014) | THE RATE AND CHARACTERS OF MASKED ARTERIAL HYPERTENSION AND MASKED INEFFECTIVENESS OF HYPERTENSION TREATMENT IN INDUSTRIAL WORKERS ACCORDING TO THE PREVENTIVE EXAMINATION | Abstract similar documents |
| M. I. Smirnova, E. M. Platonova, A. N. Britov, V. M. Gorbunov, A. D. Deev, Y. N. Koshelyaevskaya | ||
| "... measurement methods, especially ABPM, as well as standard risk factors detection are necessary for early ..." | ||
| Vol 15, No 6 (2019) | Characteristics of Patients with Reproducible Masked Hypertension and its Diagnosis Approach | Abstract similar documents |
| М. I. Smirnova, V. M. Gorbunov, Ya. N. Koshelyaevskaya, A. D. Deev, D. A. Volkov, N. V. Furman, P. V. Dolotovskaya | ||
| "... cardiology due to the association of this blood pressure (BP) phenotype with doubled cardiovascular risk ..." | ||
| Vol 3, No 3 (2007) | MAXIMAL REDUCTION OF CARDIOVASCULAR COMPLICATIONS RISK – THE MAIN TASK OF MODERN THERAPY FOR HIGH RISK PATIENTS. RANDOMIZED STUDY ON COMPREHENSIVE CONTROL ON ARTERIAL HYPERTENSION AND DYSLIPIDAEMIA | Abstract similar documents |
| N. P. Kutishenko, V. V. Yakusevich, A. A. Seragzim, A. D. Deev, S. Y. Martsevich | ||
| "... Maximal reduction of cardiovascular complications risk – the main task of modern therapy for high ..." | ||
| Vol 4, No 1 (2008) | WHAT CAN WE EXPECT USING ACE INHIBITOR RAMIPRIL IN PERSONS WITH HIGH CARDIOVASCULAR RISK AND EARLY DISORDERS OF CARBOHYDRATE METABOLISM? LESSONS OF DREAM TRIAL | Abstract similar documents |
| M. N. Mamedov, M. B. Stroeva | ||
| "... Primary prevention of diabetes in persons with high cardiovascular risk is an actual problem ..." | ||
| Vol 15, No 4 (2019) | The Study of the Fixed Dose Combination of Lisinopril with Prolonged Indopamide (FIXLINDA) with Daily Blood Pressure Monitoring and Diuresis in Hypertensive Patients | Abstract similar documents |
| M. P. Savenkov, S. N. Ivanov, M. P. Mikhaylusova, M. V. Borschevskaya, A. M. Savenkova, N. Y. Kozachenko, E. S. Sherifova | ||
| "... cardiovascular risk, without severe comorbid diseases, who were prescribed a fixed dose combination of lisinopril ..." | ||
| Vol 13, No 3 (2017) | ARTERIAL STIFFNESS AND CARDIOVASCULAR RISK FACTORS IN YOUNG MEN (41-44 YEARS) | Abstract PDF (Eng) similar documents |
| O. Yu. Isaykina, V. B. Rozanov, E. Yu. Zvolinskaya, H. S. Pugoeva, A. A. Alexandrov | ||
| "... Aim. To study the relationship of individual cardiovascular risk factors with arterial stiffness ..." | ||
| Vol 15, No 2 (2019) | Modern Recommendations and Real Clinical Practice: the Results of the SILA Study | Abstract similar documents |
| O. A. Kislyak, I. I. Chukaeva, V. A. Vygodin | ||
| "... a very high risk by SCORE scale. Prescribed therapy: SPCs amlodipine/perindopril (54%) and amlodipine ..." | ||
| Vol 20, No 1 (2024) | Features of antihypertensive therapy in the Russian population: data from the ESSE-RF3 study | Abstract similar documents |
| Yu. A. Balanova, S. A. Shalnova, V. A. Kutsenko, A. E. Imaeva, O. E. Ivlev, S. E. Evstifeeva, A. V. Kapustina, M. B. Kotova, S. A. Maksimov, G. A. Muromtseva, T. V. Repkina, T. O. Gonoshilova, A. V. Kudryavtsev, N. I. Belova, L. L. Shagrov, M. A. Samotrueva, A. L. Yasenyavskaya, O. A. Bashkina, S. V. Glukhovskaya, I. A. Levina, E. B. Dorzhieva, E. Z. Urbanova, N. Yu. Borovkova, V. K. Kurashin, A. S. Tokareva, Yu. I. Ragino, G. I. Simonova, A. D. Khudyakova, V. N. Nikulin, O. R. Aslyamov, G. V. Khokhlova, A. V. Solovieva, A. A. Rodionov, O. V. Kryachkova, Yu. Yu. Shamurova, E, V. Mikhailov, Yu. O. Tarabrina, M. G. Ataev, M. O. Radzhabov, Z. M. Gasanova, M. A. Umetov, I. A. Hakuasheva, i. V. Elgarova, E. I. Yamashkina, L. А. Balykova, A. A. Usanova, A. M. Nikitina, N. V. Savvina, Iu. E. Spiridonova, E. A. Naumova, V. S. Yudin, A. A. Keskinov, S. M. Yudin, A. V. Kontsevaya, O. M. Drapkina | ||
| "... 35 до 74 лет с установленным диагнозом артериальной гипертонии (АГ) на основании данных, полученных в ..." | ||
| Vol 13, No 5 (2017) | EFFECT OF LISINOPRIL ON 24-HOUR BLOOD PRESSURE AND ARTERIAL STIFFNESS IN PATIENTS WITH ARTERIAL HYPERTENSION AND RHEUMATOID ARTHRITIS | Abstract similar documents |
| O. L. Sarkisova, N. V. Rebrova, I. I. Bogomolova, E. A. Anisimova, R. S. Karpov, V. F. Mordovin, T. G. Khruleva | ||
| "... . A high incidence of traditional cardiovascular risk factors was identified: 95% of patients had ..." | ||
| Vol 2, No 4 (2006) | EFFECTS OF ENALAPRIL ON ENDOTHELIUM FUNCTION IN PATIENTS WITH ISCHEMIC HEART DISEASE | Abstract similar documents |
| L. I. Katelnizkaya, L. A. Chaischeva | ||
| "... ) and the influence of angiotensin converting enzyme inhibitor enalapril (Enam, Dr .Reddy’s, India) on it. Material ..." | ||
| Vol 16, No 4 (2020) | Combined Therapy of Arterial Hypertension. The Opinion of a Clinical Pharmacologist | Abstract similar documents |
| M. V. Zhuravleva, E. V. Luchinina, T. V. Shelekhova, S. Yu. Serebrova, S. A. Belkov, A. I. Dmitriev, G. I. Gorodetskaya | ||
| "... and combination therapy. Monotherapy is recommended primarily for low-risk patients with systolic blood pressure ..." | ||
| Vol 14, No 5 (2018) | The Potential of the Volumetric Sphygmography for the Diagnosis of Impaired Arterial Stiffness in Patients with Uncomplicated Arterial Hypertension and Its Possibilities for Evaluation of the Antihypertensive Therapy Effectiveness | Abstract similar documents |
| E. V. Borisova, A. I. Kochetkov, O. D. Ostroumova | ||
| "... артериальной гипертонией (АГ) II стадии 1-2 степени и их динамики на фоне лечения фиксированными комбинациями ..." | ||
| Vol 14, No 1 (2018) | PROBLEMS OF EVALUATING BLOOD PRESSURE MEASUREMENT IN MODERN CLINICAL TRIALS (THE CASE OF SPRINT STUDY RESULTS) | Abstract similar documents |
| V. M. Gorbunov | ||
| "... trial was to prove the benefit of reducing systolic BP (SBP) below 120 mm Hg in high-risk hypertensive ..." | ||
| Vol 15, No 4 (2019) | Antihypertensive and Target-Organ Protective Properties of Telmisartan and Hydrochlorothiazide Single-Pill Combination | Abstract similar documents |
| O. D. Ostroumova, A. I. Kochetkov | ||
| "... of cardiovascular risk. Telmisartan also provide powerful target-organ protection realized at the level of all AH ..." | ||
| Vol 19, No 6 (2023) | Acute kidney injury as a risk factor for atrial fibrillation after coronary artery bypass grafting — effects of sodium-glucose cotransporter-2 inhibitors | Abstract similar documents |
| L. V. Kremneva, L. A. Arutyunyan, L. I. Gapon, S. N. Suplotov, S. V. Shalaev | ||
| "... ,5%, нарушения углеводного обмена — 35,6%, артериальную гипертонию — 96,7%, хроническую болезнь почек (ХБП) — 23 ..." | ||
| Vol 4, No 5 (2008) | ANTIHYPERTENSIVE THERAPY IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE: ADVANTAGES OF CALCIUM ANTAGONISTS | Abstract similar documents |
| T. V. Adasheva, I. V. Fedorova, V. S. Zadionchenko, M. V. Macievich, V. V. Lee, S. V. Pavlov | ||
| "... Aim. To study effect of antihypertensive therapy with amlodipine maleat (Stamlo® M, “Dr. Reddy’s ..." | ||
| Vol 9, No 6 (2013) | СARDIOPROTECTION IN PATIENTS WITH HYPERTENSION – THE ROLE OF LOSARTAN | Abstract similar documents |
| I. I. Chukaeva, Ya. G. Spiryakina | ||
| "... the presence of LVH and increased cardiovascular risk, the deterioration of the clinical course and prognosis ..." | ||
| Vol 7, No 4 (2011) | PERINDOPRIL: THE POSSIBILITY OF ANTIHYPERTENSIVE AND RENOPROTECTIVE THERAPY | Abstract similar documents |
| O. V. Dralova, M. L. Maksimov | ||
| "... problems in modern cardiology and nephrology. Perindopril therapy reduces cardiovascular risk in patients ..." | ||
| Vol 13, No 4 (2017) | CLINICAL ADVANTAGES OF TELMISARTAN: FEATURES OF PHARMACOKINETICS, PHARMACODYNAMICS AND EFFECTS ON THE DAILY BLOOD PRESSURE PROFILE | Abstract similar documents |
| O. D. Ostroumova, E. A. Smolyarchuk, O. V. Bondarec, E. E. Paleeva | ||
| "... rises in the early morning hours increase the risk of cardiovascular and cerebrovascular complications ..." | ||
| Vol 6, No 5 (2010) | FIXED LOW-DOSE COMBINATION OF LISINOPRIL AND HYDROCHLOROTHIAZIDE IN THE PREVENTION OF CARDIOVASCULAR EVENTS IN HYPERTENSIVE PATIENTS | Abstract similar documents |
| A. O. Shevchenko, O. P. Shevchenko | ||
| "... to more effective blood pressure control, organoprotection improvement and side events risk reduction ..." | ||
| Vol 15, No 4 (2019) | Evidence, Guidelines and Treatment Algorithms for Patients with Arterial Hypertension and Dyslipidemia: the Need for Compromise and Optimization of Tactics in Practical Healthcare | Abstract similar documents |
| O. M. Drapkina, M. V. Ezhov, S. R. Gilyarevsky, R. N Shepel | ||
| "... , are discussed. Data on the narrow-mindedness of use of risk assessment scales for the development ..." | ||
| Vol 5, No 6 (2009) | RESULTS OF THE CAMELLIA TRAIL: IMPLEMENTATION IN A PRIMARY HEALTH CARE | Abstract similar documents |
| G. I. Nechaeva, E. N. Loginova | ||
| "... pressure (BP) level, body mass index, biochemical markers and risk factors were evaluated initially ..." | ||
| Vol 17, No 4 (2021) | Arterial hypertension and antihypertensive therapy in older patients. The agreed opinion of experts from the Russian Association of Gerontologists and Geriatricians, the Antihypertensive League, the National Society for Preventive Cardiology | Abstract similar documents |
| O. N. Tkacheva, Yu. V. Kotovskaya, N. K. Runikhina, E. V. Frolova, V. S. Ostapenko, N. V. Sharashkina, E. I. Baranova, S. V. Bulgakova, S. V. Villevalde, D. V. Duplyakov, A. N. Ilnitskiy, O. A. Kislyak, Zh. D. Kobalava, A. O. Konradi, S. V. Nedogoda, Ya. A. Orlova, N. V. Pogosova, K. I. Proshchaev, G. A. Chumakova | ||
| "... High blood pressure is a risk factor for cardiovascular morbidity and mortality, as well ..." | ||
| Vol 5, No 2 (2009) | POSSIBILITY OF BONE METABOLISM MODULATOR (STRONTIUM RANELATE) USAGE FOR THE TREATMENT OF WOMEN WITH POSTMENOPAUSAL OSTEOPOROSIS AND ARTERIAL HYPERTENSION | Abstract similar documents |
| N. J. Hozjainova, V. M. Tsareva, T. V. Brook, M. S. Bezaltynnyh | ||
| "... ) and medium/high cardiovascular risk were included in the study. 23 patients of the main group received ..." | ||
| Vol 15, No 2 (2019) | Association between Sympathetic Nervous System Activation, Obesity and Insulin Resistance | Abstract similar documents |
| A. I. Kochetkov, O. D. Ostroumova, A. V. Starodubova, Т. М. Оstroumova, D. A. Bondarenko | ||
| "... cardiovascular risk. The mechanisms of sympathetic overactivity in obesity, including insulin resistance ..." | ||
| Vol 12, No 4 (2016) | Resistant hypertension: epidemiology and risk factors | Abstract similar documents |
| I. E. Deneka, A. A. Svetankova, A. V. Rodionov | ||
| "... to treatment and non-rational therapy, there are other objective risk factors of resistance. Three main ..." | ||
| Vol 14, No 5 (2018) | Associations of Cardiovascular Risk Factors and Genetic Markers with Development of Arterial Hypertension in the Population of Mountain Shoriya | Abstract similar documents |
| T. A. Mulerova, S. A. Maksimov, M. Yu. Ogarkov, O. V. Gruzdeva, A. V. Ponasenko, V. N. Maksimov, M. I. Voyevoda, E. S. Filimonov, G. V. Artamonova | ||
| "... Aim. To study the combined effect of cardiovascular risk factors and genetic markers that encode ..." | ||
| Vol 5, No 2 (2009) | COMPARISON OF THE METABOLIC EFFECTS OF CARVEDILOL AND METОPROLOL IN HYPERTENSIVE PATIENTS WITH OVERWEIGHT AND OBESITY. THE CAMELLIA TRIAL | Abstract similar documents |
| S. Y. Martsevich, N. P. Kutishenko, E. V. Shilova, A. D. Deev, S. A. Shalnova, R. G. Oganov, I. A. Veliganina, E. G. Volkova, Yu. E. Voskanjan, L. I. Gapon, P Ya. Dovgalevskij, V. Ya. Ermolina, E. M. Idrisova, N. N. Ilov, A. R. Kiselev, S. Yu. Levashov, V. A. Nevzorova, G. I. Nechaeva, T. N. Panova, I. I. Reznik, V. V. Skibickij, L. A. Sokolova, V. P. Terentev, N. V. Hailo, A. V. Shabalin, T. V. Shnjukova, V. V. Yakusevich | ||
| "... hypertension and metabolic risk factors. ..." | ||
| Vol 7, No 2 (2011) | EFFICACY AND SAFETY OF BISOPROLOL IN YOUNG MEN WITH ARTERIAL HYPERTENSION AND OBESITY | Abstract similar documents |
| A. G. Avtandilov, I. I. Esenova, S. L. Petrosov | ||
| "... demonstrated metabolic neutrality in patients with risk factors of cardiovascular diseases and type 2 diabetes. ..." | ||
| Vol 17, No 4 (2021) | Epidemiological Observational Study on the Assessment of the Comorbidity and the Efficacy of the Treatment of Hypertensive Patients with Single Pill Combination of Lysinopril, Amlodipine and Rosuvastatin "PHENOTYPE-AG" | Abstract similar documents |
| M. P. Savenkov, S. N. Ivanov, M. V. Borschevskaya, I. N. Okuneva, S. V. Ivanova, A. M. Savenkova, R. V. Dushkin | ||
| "... cardiovascular risk and dyslipidemia treated with SPC LAR were held in 24 cities of Russia from November 2020 ..." | ||
| Vol 8, No 6 (2012) | ASSESSMENT OF DIABETES RISK IN MEN WITH DIFFERENT LEVELS OF CARDIOVASCULAR RISK | Abstract similar documents |
| M. N. Kovrigina, M. N. Mamedov | ||
| "... Aim. To assess the risk of diabetes mellitus type 2 (DM2) in patients with various cardiovascular ..." | ||
| Vol 2, No 1 (2006) | ANTIHYPERTENSIVE TREATMENT WITH COMBINED DRUG OF LOSARTAN AND HYDROCHLOROTHIAZIDE | Abstract similar documents |
| R. M. Linchak, K. M. Shumilova, A. D. Martinyuk, T. A. Gusaim, E. V. Semyonova, L. G. Zhirova, S. A. Boitsov | ||
| "... and very high cardiovascular risk. Material and methods: 30 patients with AH of I-III grade (13 men and 17 ..." | ||
| Vol 15, No 5 (2019) | Outpatient Register of Patients with Acute Myocardial Infarction: Assessment of the Hypertension Impact on Long-term Prognosis | Abstract similar documents |
| D. P. Sichinava, E. P. Kalaydzhyan, N. P. Kutishenko, S. Yu. Martsevich | ||
| "... .41). There was no statistically significant effect of AH on long-term outcomes of AMI, adjusted risk ratio =1.30 [95% confidence ..." | ||
| Vol 13, No 5 (2017) | ARTERIAL HYPERTENSION IN THE PRESENCE OF OVERWEIGHT AND OBESITY. THE CAPABILITIES OF AMLODIPINE AND LISINOPRIL COMBINATION. PART 1. FEATURES OF THE DAILY PROFILE OF BLOOD PRESSURE AND HEART DAMAGE AS A TARGET ORGAN IN PATIENTS WITH ARTERIAL HYPERTENSION IN COMBINATION WITH OVERWEIGHT AND OBESITY | Abstract similar documents |
| O. D. Ostroumova, A. I. Kochetkov, I. I. Kopchjonov, V. M. Fomina | ||
| "... of arterial hypertension (HT), and also increase the risk of cardiovascular complications are discussed ..." | ||
| Vol 16, No 4 (2020) | How to Choose the Optimal Single-Pill Combination of the First-Line Antihypertensive Drugs? The Benefits of Amlodipine and Telmisartan Combination | Abstract similar documents |
| O. D. Ostroumova, A. I. Kochetkov, V. N. Butorov, I. F. Krotkova | ||
| "... are recognized cardiovascular risk factors. Currently, in the vast majority of hypertensive patients, the main ..." | ||
| Vol 5, No 3 (2009) | RISK FACTORS OF THE ERECTILE DYSFUNCTION IN THE PATIENTS WITH CARDIOVASCULAR DISEASES | Abstract similar documents |
| E. V. Minakov, R. A. Khokhlov, T. N. Kuznetsova, Y. V. Popovskaya, D. V. Snustikov, E. E. Tsareva, V. I. Yarliykova, N. M. Akhmedzhanov | ||
| "... ) and/or coronary heart disease (CHD) as well as to study risk factors of erectile dysfunction. Material ..." | ||
| Vol 14, No 6 (2018) | Different Types of Blood Pressure Variability in Hypertensive Patients with Chronic Lower Airway Diseases | Abstract PDF (Eng) similar documents |
| M. I. Smirnova, V. M. Gorbunov, A. S. Kurekhyan, Ya. N. Koshelyaevskaya, A. D. Deev | ||
| "... inhalation, and GFR. In the CLAD group, the cumulative survival was lower, while the total risk was higher ..." | ||
| Vol 5, No 3 (2009) | CLINICAL AND ECONOMICAL RATIONALES OF CARDIOVASCULAR RISK EVALUATION AT WORKPLACE | Abstract similar documents |
| A. V. Kontsevaya, A. M. Kalinina, Yu. M. Pozdnyakov, S. V. Belonosova, M. B. Khudyakov | ||
| "... Aim. To study clinical and economical rationales for cardiovascular risk evaluation at workplace ..." | ||
| Vol 19, No 1 (2023) | Arterial Hypertension and Severe COVID-19 in Hospitalized Patients: Data from a Cohort Study | Abstract PDF (Eng) similar documents |
| V. I. Podzolkov, A. E. Bragina, A. I. Tarzimanova, L. V. Vasilyeva, E. S. Ogibenina, E. E. Bykova, I. I. Shvedov, A. A. Ivannikov, N. A. Druzhinina | ||
| "... regression was performed to assess the independent association between risk factors and endpoints. Results ..." | ||
| Vol 8, No 6 (2012) | THE RELATIONSHIP OF CARDIOVASCULAR RISK FACTORS AND ARTERIAL WALL STIFFNESS IN WOMEN WITH A HIGH ACTIVITY OF RHEUMATOID ARTHRITIS | Abstract similar documents |
| D. S. Novikova, T. V. Popkova, A. N. Gerasimov, A. V. Volkov, E. L. Nasonov | ||
| "... pulse wave) with cardiovascular risk factors in women with rheumatoid arthritis (RA). Material ..." | ||
| Vol 9, No 1 (2013) | CLINICAL AND COST EFFECTIVENESS OF PREVENTIVE COUNSELING OF YOUNG PATIENTS WITH ARTERIAL HYPERTENSION IN PRIMARY HEALTH CARE | Abstract similar documents |
| M. I. Shupina, O. Ju. Korennova, E. N. Loginova | ||
| "... . The total cardiovascular risk in patients of “Health school” and "Typical practice" groups after 12 months ..." | ||
| Vol 15, No 2 (2019) | Screening of People with High Blood Pressure in Moscow Region | Abstract similar documents |
| O. M. Drapkina, R. N. Shepel, E. S. Ivanova, E. S. Bulgakova, A. N. Kaburova, L. M. Zhamalov, Yu. D. Shalyagin, A. V. Kutcher, S. A. Vernadskiy | ||
| "... Region citizens about high blood pressure (BP) and draw their attention to this important risk factor ..." | ||
| Vol 6, No 4 (2010) | ACE INHIBITOR POSSIBILITIES IN CLINICAL PRACTICE: WHAT WE KNOW ABOUT THEM? | Abstract similar documents |
| D. V. Nebieridze, A. S. Safarian | ||
| "... ингибиторов АПФ (иАПФ). Широко известны традиционные ниши применения иАПФ — артериальная гипертония, сердечная ..." | ||
| Vol 8, No 5 (2012) | THE ROLE OF BETA-BLOCKERS IN THE TREATMENT OF CARDIOVASCULAR DISEASES IN PREGNANT WOMEN | Abstract similar documents |
| R. I. Striuk, Ya. V. Brytkova | ||
| "... in different clinical situations meets the principle of "risk–benefit". Fetus and newborn status should ..." | ||
| Vol 16, No 1 (2020) | High Blood Pressure Variability is an Additional Cardiovascular Risk Factor | Abstract similar documents |
| A. V. Rodionov | ||
| "... that increased BP variability is an independent prognostic factor that increases the risk of cardiovascular ..." | ||
| Vol 4, No 5 (2008) | AMLODIPINE ADVANTAGES IN ARTERIAL HYPERTENSION THERAPY | Abstract similar documents |
| V. M. Tsareva, N. J. Hozjainova, M. S. Bezaltynnyh, T. V. Brook, N. A. Borohova, I. E. Koltunov, N. M. Ahmedzhanov | ||
| "... , структурно-функциональные показатели сердца и микроциркуляцию у больных артериальной гипертонией (АГ ..." | ||
| Vol 11, No 2 (2015) | THE EFFECTIVENESS OF LERCANIDIPINE IN REDUCING THE RISK OF ARTERIAL HYPERTENSION COMPLICATIONS | Abstract similar documents |
| E. EL. Trisvetova | ||
| "... Despite progress in reducing the risk of hypertension (HT) complications, control of blood ..." | ||
| Vol 4, No 4 (2008) | CHOICE OF ANTIHYPERTENSIVE THERAPY IN PATIENTS WITH ARTERIAL HYPERTENSION AND CHRONIC LIVER DISEASES | Abstract similar documents |
| M. N. Mamedov, O. M. Drapkina | ||
| "... выросло. Среди пациентов с артериальной гипертони- ей (АГ) наряду с метаболическими факторами риска ..." | ||
| Vol 15, No 2 (2019) | Mammographic Screening as a Tool for Cardiovascular Risk Assessing. Part 1. Breast Arterial Calcification: Pathomorphology, Prevalence and Risk Factors | Abstract similar documents |
| E. V. Bochkareva, I. V. Kim, E. K. Butina, I. D. Stulin, S. A. Trukhanov, B. A. Rudenko, S. A. Boytsov, O. M. Drapkina | ||
| "... with cardiovascular diseases (CVD). This allows it to be considered as a new marker of cardiovascular risk in women ..." | ||
| Vol 13, No 6 (2017) | ARTERIAL HYPERTENSION IN THE PRESENCE OF OVERWEIGHT AND OBESITY. THE CAPABILITIES OF AMLODIPINE AND LISINOPRIL COMBINATION. Part 2. Antihypertensive and Organoprotective Effects of Amlodipine/Lisinopril Fixed-Dose Combination in Patients with Arterial Hypertension in the Presence of Overweight and Obesity | Abstract similar documents |
| O. D. Ostroumova, A. I. Kochetkov, I. I. Kopchjonov, V. M. Fomina | ||
| "... ventricular hypertrophy are considered as "new" risk factors in hypertensive patients along with disturbances ..." | ||
| Vol 3, No 1 (2007) | DIHYDROPYRIDINE CALCIUM ANTAGONISTS: DATA OF EVIDENCE BASED MEDICINE AND RECOM-MENDATIONS ON PRACTICAL USE | Abstract similar documents |
| S. Y. Martsevich | ||
| "... on the risk of cardiovascular complications. The place of dihydropyridine calcium antagonists in modern ..." | ||
| Vol 17, No 1 (2021) | Optimization of Pharmacotherapy Within the Framework of a Patient-oriented Approach in the Treatment of Hypertension in Multimorbidity Patients (Clinical Case and Literature Review) | Abstract similar documents |
| O. D. Ostroumova, I. A. Alyautdinova, S. N. Litvinova, A. V. Arablinskij, A. A. Kirichenko | ||
| "... , including in Russia. At the same time, the risks of coronary and cerebrovascular events increase ..." | ||
| Vol 5, No 3 (2009) | ARTERIAL STIFFNESS PARAMETERS IN PATIENTS WITH MODERATE/HIGH CARDIOVASCULAR RISK DURING LISINOPRIL AND SIMVASTATIN TREATMENT | Abstract similar documents |
| V. N. Isakova, O. G. Garbuzova, E. V. Klinkova, E. V. Bandurko | ||
| "... with moderate/high cardiovascular risk receiving lisinopril and simvastatin. Material and methods. 20 patients ..." | ||
| Vol 3, No 5 (2007) | FEMALE SEX HORMONES AS MODULATORS OF GENDER DIFFERENCES IN RESPONSE TO PHARMACOTHERAPY OF CARDIOVASCULAR DISEASES | Abstract similar documents |
| S. N. Tereshchenko, I. V. Zhirov, E. S. Krasilnikova, E. E. Kazantseva | ||
| "... increased in women. The risk of cardiovascular diseases in premenopausal women is 2-4 times less than ..." | ||
| 1 - 100 of 1186 Items | 1 2 3 4 5 6 7 8 9 10 > >> | |
Search tips:
- Search terms are case-insensitive
- Common words are ignored
- By default articles containing any term in the query are returned (i.e., OR is implied)
- Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
- Combine multiple words with AND to find articles containing all terms; e.g., education AND research
- Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
- Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
- Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)
